Quick answer: At ARDD 2026, the world’s leading longevity research meeting held October 1-3 at Harvard, regulators, Big Pharma and scientists agreed on a new standard: longevity therapies must prove measurable benefits in humans, not just longer mouse lives. The ARDD 2026 longevity pivot means intrinsic capacity scores, functional endpoints like VO2 max and aging […]